CCL11

Hemokin (C-C motiv) ligand 11
PDB prikaz baziran na 1eot​.
Dostupne strukture
1eot​, 2eot
Identifikatori
Simboli CCL11; MGC22554; SCYA11
Vanjski ID OMIM601156 MGI103576 HomoloGene7929 GeneCards: CCL11 Gene
Pregled RNK izražavanja
podaci
Ortolozi
Vrsta Čovek Miš
Entrez 6356 20292
Ensembl ENSG00000172156 ENSMUSG00000020676
UniProt P51671 Q5SVB5
RefSeq (mRNA) NM_002986 NM_011330
RefSeq (protein) NP_002977 NP_035460
Lokacija (UCSC) Chr 17:
29.64 - 29.64 Mb
Chr 11:
81.87 - 81.88 Mb
PubMed pretraga [1] [2]

CCL11, hemokin (C-C motiv) ligand 11, je mali citokin iz CC hemokin familije. On je takođe poznat kao eotaksin-1. CCL11 selektivno regrutuje eozinofile putem indukovanja njihove hemotakse, i zato je impliciran u alergijske response.[1][2][3]

Efekti CCL11 su posredovani njegovim vezivanjem za G-protein spregnuti hemokin receptor. Hemokin receptori CCL11 liganda su CCR2[4], CCR3[5] i CCR5.[4] Međutim, bilo je ustanovljeno da eotaksin-1 (CCL11) ima visok stepen selektivnosti za CCR3 receptor, tako da je neaktivan na neutrofilima i monocitima, koji ne izražavaju CCR3.[6] Gen ljudskog CCL11 (SCYA11) je kodiran sa tri eksona i lociran je na hromozomu 17.[5][7]

Reference

  1. ^ Ponath PD, Qin S, Ringler DJ, Clark-Lewis I, Wang J, Kassam N, Smith H, Shi X, Gonzalo JA, Newman W, Gutierrez-Ramos JC, Mackay CR (1996). „Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils”. J. Clin. Invest.. 97 (3): 604—12. PMC 507095Слободан приступ. PMID 8609214. doi:10.1172/JCI118456. [мртва веза]
  2. ^ Garcia-Zepeda EA, Rothenberg ME, Ownbey RT, Celestin J, Leder P, Luster AD (1996). „Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia”. Nat. Med.. 2 (4): 449—56. PMID 8597956. doi:10.1038/nm0496-449. 
  3. ^ Mire-Sluis, Anthony R.; Thorpe, Robin, ур. (1998). Cytokines (Handbook of Immunopharmacology). Boston: Academic Press. ISBN 0-12-498340-5. 
  4. ^ а б Ogilvie P, Bardi G, Clark-Lewis I, Baggiolini M, Uguccioni M (2001). „Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5”. Blood. 97 (7): 1920—4. PMID 11264152. doi:10.1182/blood.V97.7.1920. 
  5. ^ а б Kitaura M, Nakajima T, Imai T, Harada S, Combadiere C, Tiffany HL, Murphy PM, Yoshie O (1996). „Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3”. J. Biol. Chem.. 271 (13): 7725—30. PMID 8631813. doi:10.1074/jbc.271.13.7725. 
  6. ^ Baggiolini M, Dewald B, Moser B (1997). „Human chemokines: an update”. Annu. Rev. Immunol.. 15: 675—705. PMID 9143704. doi:10.1146/annurev.immunol.15.1.675. 
  7. ^ Hein H, Schlüter C, Kulke R, Christophers E, Schröder JM, Bartels J (1997). „Genomic organization, sequence, and transcriptional regulation of the human eotaxin gene”. Biochem. Biophys. Res. Commun.. 237 (3): 537—42. PMID 9299399. doi:10.1006/bbrc.1997.7169. 

Literatura

Spoljašnje veze


Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.